Many are asking why is SpaceX, $SPCX, NOT trading yet?
Here's exactly how the IPO process works and when the shares will be available to trade (Bookmark this):
The IPO was quoted at 9:50 AM ET and was expected to begin trading at 10:00 AM ET, but that does NOT guarantee shares will trade at that time.
Before trading begins, Nasdaq must complete a price-discovery auction where buy and sell orders are collected and matched.
At around 9:50 AM ET, "first indications" came out which are essentially a "gauge" of where the stock will open.
The first indications on $SPCX came in at $175/share, or a ~30% premium to the $135/share IPO price.
During this process:
1. Orders are entered, but no trades occur yet
2. Nasdaq continuously updates the indicative opening price
3. The opening price is adjusted until supply and demand are balanced
4. Only then does the opening auction occur and the first trade print
For major IPOs, delays are common such as Google in 2004 and Meta in 2012 which saw their first trades over 2 hours after the US market opened.
We expect the SpaceX IPO to open for trading within the next 60 minutes.
Buckle up for a historic day.
A nun was assaulted in occupied East Jerusalem earlier this week amid growing concern over Israeli attacks against Christians.
The 48-year-old, a researcher at Jerusalem’s French School of Biblical and Archaeological Research, was attacked on Tuesday in front of the Cenacle, a site on Mount Zion regarded as holy by both Christians and Jews.
The Hebrew University of Jerusalem, which is affiliated with the nun’s research centre, said the attack was “not an isolated incident, but part of a troubling pattern of rising hostility toward the Christian community and its symbols”.
🚨 BREAKING: Leaked footage reveals a new crime unfolding in Gaza.
Israeli forces are demolishing one of the last remaining schools, deliberately wiping out what survives of Gaza’s education system. This is happening under a so-called “ceasefire.”
Hussam Abu Safieh is one of the Palestinian doctors (among 95 other doctors) that will be killed by the “Israeli death penalty for hostages.”
Do not let them murder him. Repost this.
BREAKING:
Israeli government passed a law approving the execution of Palestinian prisoners, with no age minimum, no chance of pardon or sentence reduction.
It will be implemented in 90 days. They will now hang children for insulting Israel.
May Allah stop them. Repost this.
BREAKING : 🇨🇦 Canadian leader Elizabeth May blasted Netanyahu
“We know who the enemy of peace is. And unfortunately, he has a name. He is Israeli PM Benjamin Netanyahu” 🔥
What a fearless lady. Mad respect 🫡
One of the most brutal scenes in human history has been exposed.
Israeli soldiers opened fire on thousands of starving Gazans as they ran in desperation for a piece of food during the war on Gaza.
A moment the world must never forget.
BREAKING: Elon Musk has announced that @Tesla is discontinuing the Model S and Model X in Q2 2026.
"We are going to convert that production space to an Optimus factory. It's part of our overall shift to an autonomous future."
Researchers at the University of Pennsylvania have developed an innovative antiviral chewing gum that neutralizes over 95% of certain viruses in saliva, offering a simple, plant-based way to potentially curb transmission through everyday chewing.
Led by Henry Daniell at Penn's School of Dental Medicine, the team created a clinical-grade gum incorporating a natural antiviral trap protein called FRIL (Flt3 Receptor Interacting Lectin), derived from lablab beans (Lablab purpureus, also known as hyacinth beans). This protein binds to complex-type N-glycans on the envelopes of various viruses, entrapping them and preventing infection or spread.
Building on earlier work with a different gum containing plant-produced ACE2 (which reduced SARS-CoV-2 in saliva samples by >95% and is now in clinical trials), the latest formulation targets a broader range of pathogens. Lab tests showed that just 40 mg of the bean-based gum (from a 2-gram tablet) achieved more than 95% reduction in viral loads for influenza A strains (H1N1 and H3N2) and herpes simplex viruses (HSV-1 and HSV-2). The gum releases FRIL effectively during chewing, acting as a molecular decoy right at the site of viral replication in the mouth—key for limiting spread via talking, coughing, sneezing, or close contact.
The product is engineered for real-world practicality: it remains stable and fully functional at room temperature for over 790 days, meets FDA clinical-grade standards, and uses safe, natural ingredients. While the ACE2 version (targeting COVID-19) has advanced to human trials, this FRIL-based gum shows strong promise for seasonal threats like flu and herpes, and researchers are even exploring lablab bean powder against bird flu (H5N1) in animal feed.
If proven effective in upcoming clinical studies, this could become a low-cost, non-invasive tool for high-risk settings—schools, dental offices, public transport, or during outbreaks—helping reduce oral viral transmission without drugs or vaccines.
[Daniell et al., "Debulking influenza and herpes simplex virus strains by a wide-spectrum anti-viral protein formulated in clinical grade chewing gum," Molecular Therapy (2024). DOI: 10.1016/j.ymthe.2024.12.008]